Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)

Vettor, RobertoPetroni, Maria LetiziaDotan, IditLalazar, GadiHaluzík, MartinSpearman, C. WendyDave, Joel A.Abaalkhail, FaisalAbusnana, SalahAlshehri, AliBruha, RadanHarangi, MariannJazzar, AhmadKukla, MichałKumar, ShivaLambadiari, VaiaPapatheodoridis, GeorgePapp, MáriaPetta, SalvatorePop, Corina SilviaStoian, Anca PanteaTomasiewicz, Krzysztof2026-05-062026-05-062026Reviews In Endocrine & Metabolic Disorders. -27 : 2 (2026), p. 213-235. -Rev. Endocr. Metab. Disord. - 1389-91551389-9155https://hdl.handle.net/2437/406816Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)folyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM137130OrvostudományokKlinikai orvostudományokhttps://link.springer.com/10.1007/s11154-026-10027-8szerzőhttp://dx.doi.org/10.1007/s11154-026-10027-82026-05-06001757673000001105038132977